Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-14T22:57:57.483Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost Analysis of Computerized Clinical Decision Support and Trainee Financial Incentive for Clostridioides difficile Testing

Published online by Cambridge University Press:  23 November 2018

Gregory R. Madden Open the ORCID record for Gregory R. Madden [Opens in a new window] ,
Heather L. Cox ,
Melinda D. Poulter ,
Jason A. Lyman ,
Kyle B. Enfield Open the ORCID record for Kyle B. Enfield [Opens in a new window]  and
Costi D. Sifri Open the ORCID record for Costi D. Sifri [Opens in a new window]
Gregory R. Madden
Affiliation:
Division of Infectious Diseases & International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
Heather L. Cox
Affiliation:
Division of Infectious Diseases & International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia Department of Pharmacy Services, University of Virginia Health System, Charlottesville, Virginia
Melinda D. Poulter
Affiliation:
Clinical Microbiology Laboratory, Department of Pathology, University of Virginia Health System, Charlottesville, Virginia
Jason A. Lyman
Affiliation:
Department of Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia
Kyle B. Enfield
Affiliation:
Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
Costi D. Sifri*
Affiliation:
Division of Infectious Diseases & International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia Office of Hospital Epidemiology/Infection Prevention & Control, University of Virginia Health System, Charlottesville, Virginia
*
Author for correspondence: Costi D. Sifri, Division of Infectious Diseases & International Health, University of Virginia Health System, PO Box 800473, Charlottesville, VA 22908–0473. E-mail: csifri@virginia.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Brief
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 2 , February 2019 , pp. 242 - 244
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: Data from this study were presented in part as an abstract at the 2018 Society for Healthcare Epidemiology of America meeting on April 19, 2018, in Portland, Oregon (abstract #327).

Cite this article: Madden GR et al. (2019) Cost analysis of computerized clinical decision support and trainee financial incentive for Clostridioides difficile testing. Infection Control & Hospital Epidemiology 2019, 40, 242–244. doi: 10.1017/ice.2018.300

References

1. Kyne, L, Hamel, MB, Polavaram, R, Kelly, CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile . Clin Infect Dis 2002;34:346–353.Google Scholar
2. Desai, K, Gupta, SB, Dubberke, ER, Prabhu, VS, Browne, C, Mast, TC. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infect Dis 2016;16:303.Google Scholar
3. Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015;175:1792–1801.Google Scholar
4. Madden, GR, Weinstein, RA, Sifri, CD. Diagnostic stewardship for healthcare-associated infections: opportunities and challenges to safely reduce test use. Infect Control Hosp Epidemiol 2018;39:214–218.Google Scholar
5. CDC/NHSN Surveillance definitions for specific types of infections. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Published January 2017. Accessed April 26, 2017.Google Scholar
6. Madden, GR, German Mesner, I, Cox, HL, et al. Reduced Clostridium difficile tests and laboratory-identified events with a computerized clinical decision support tool and financial incentive. Infect Control Hosp Epidemiol 2018;39:737–740.Google Scholar
7. McGlone, SM, Bailey, RR, Zimmer, SM, et al. The economic burden of Clostridium difficile . Clin Microbiol Infect 2012;18:282–289.Google Scholar
8. Song, X, Bartlett, JG, Speck, K, Naegeli, A, Carroll, K, Perl, TM. Rising economic impact of clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol 2008;29:823–828.Google Scholar
9. Zhang, D, Prabhu, VS, Marcella, SW. Attributable healthcare resource utilization and costs for patients with primary and recurrent Clostridium difficile infection in the United States. Clin Infect Dis 2018;359:1326–1332.Google Scholar
10. Mathers, AJ, Poulter, M, Dirks, D, Carroll, J, Sifri, CD, Hazen, KC. Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Infect Control Hosp Epidemiol 2014;35:350–355.Google Scholar